🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In recent studies, it has been reported that the renal resistance index is ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-03-30
Trial ID
NCT07472452
Treatments Being Tested
This is a non-randomized phase II trial of denosumab at 120 mg subcutaneous...
Status
Completed
Location
Stony Brook University Cancer Center
Start Date
2015-11
Trial ID
NCT02613416
Treatments Being Tested
This phase I trial studies the side effects and best dose of stereotactic b...
Status
Completed
Location
University of Wisconsin Carbone Cancer Center
Start Date
2014-04-08
Trial ID
NCT01918644
RATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor grow...
Status
Unknown
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2006-07
Trial ID
NCT00436709
This study seeks to understand the performance of MRI to characterize pancr...
Status
Enrolling By Invitation
Location
Cincinnati Children's Hospital Medical Center
Start Date
2023-01-18
Trial ID
NCT05659147
This is an imaging study designed to illuminate the function of the choline...
Status
Terminated
Location
Stony Brook Medical Center
Start Date
2021-05-27
Trial ID
NCT05034263
This phase II trial examines the use of blood-based biomarkers is to help i...
Status
Recruiting
Location
Mayo Clinic in Arizona
Start Date
2023-02-21
Trial ID
NCT05541016
Treatments Being Tested
The current trial is evaluating the integration of a pretherapeutical FDG-P...
Status
Completed
Location
University Hospital Tübingen, Department of Radiation Oncology
Start Date
2015-07
Trial ID
NCT02666885
Treatments Being Tested
The goal of this study is to develop new imaging biomarkers for quantitativ...
Status
Active Not Recruiting
Location
Washington University
Start Date
2023-10-24
Trial ID
NCT06036524
Treatments Being Tested
Hepatocellular carcinoma (HCC) is the 7th most common cause of cancer death...
Status
Active Not Recruiting
Location
National University Hospital
Start Date
2021-04-15
Trial ID
NCT04965259